Changing management of acute MI--perspectives from India.
Management of acute myocardial infarction (AMI) in India essentially rests on the established reperfusion strategies with unique adaptations compelled by the socioeconomic structure of the country. Due to limited availability of trained interventionists coupled with financial limitations, thrombolysis remains the most utilised reperfusion therapy for AMI. Patient education through the active participation of physicians concerning the early detection of symptoms suggestive of AMI can enhance the impact of thrombolysis on the outcomes by narrowing the door-to-needle time. This article discusses some of these unique issues and possible solutions in the emerging economies to optimise outcomes in AMI.
Spandan Heart Institute and Research Center, Nagpur, India.
Harshawardhan M
HM
Mardikar
Niteen V
NV
Deshpande
Parag
P
Admane
D003362:Cost-Benefit Analysis; D003906:Developing Countries / Q000191:economics; D042241:Early Diagnosis; D004632:Emergency Medical Services / Q000639:trends; D017048:Health Care Costs; D007722:Health Knowledge, Attitudes, Practice; D006297:Health Services Accessibility / Q000191:economics / Q000639:trends*; D006801:Humans; D007194:India; D009203:Myocardial Infarction / Q000175:diagnosis / Q000191:economics / Q000628:therapy*; D010353:Patient Education as Topic; D062645:Percutaneous Coronary Intervention / Q000191:economics / Q000639:trends*; D058996:Quality Improvement / Q000639:trends; D012959:Socioeconomic Factors; D015912:Thrombolytic Therapy / Q000191:economics / Q000639:trends*; D013997:Time Factors; D061665:Time-to-Treatment / Q000639:trends; D014187:Transportation of Patients / Q000639:trends; D016896:Treatment Outcome